2m 2m 2m 2m 2m 2m 2m
Lite Strategy (LITS)
NASDAQ
$1.39+$0.01 (+0.73%)
Price as of Oct 02, 2026 6:37 PM EDT- $41.8MMarket Cap
- -48.69%1-Year Change
- BiotechnologyIndustry
Lite Strategy (LITS)
$1.39+$0.01 (+0.73%)
Annual
Quarterly
06/30/2026 | 06/30/2025 | 06/30/2024 | 06/30/2023 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 0 N/A | 0 -100.00% | 65.3M +33.76% | 48.8M +19.95% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 0 N/A | 0 -100.00% | 65.3M +33.76% | 48.8M +19.95% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -122,000 -96.89% | -3.9M -76.31% | -16.6M -68.43% | -52.5M -38.76% | |
Depreciation and Amortization Expense | 0 -100.00% | 368,000 -3.92% | 383,000 -0.78% | 386,000 +18.40% | |
Total Operating Expenses | 66.6M +281.42% | 17.5M -65.61% | 50.8M -40.69% | 85.6M -26.34% | |
Operating Profit | -66.6M +281.42% | -17.5M -220.03% | 14.5M +145.44% | -32.0M -57.61% | |
Interest Income | 267,000 -73.98% | 1.0M -68.69% | 3.3M -2.03% | 3.3M +1,077.82% | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 267,000 -73.98% | 1.0M -68.69% | 3.3M -2.03% | 3.3M +1,077.82% | |
Total Nonoperating Income and Expense | -4.6M -402.85% | 1.5M -53.34% | 3.2M -34.31% | 4.9M -76.58% | |
Income before Taxes | -66.6M +281.42% | -17.5M -220.03% | 14.5M +145.44% | -32.0M -41.23% | |
Income Taxes | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Extraordinary Items | N/A N/A | 500,000 0.00% | 500,000 N/A | N/A N/A | |
Net Income | -71.2M +346.22% | -15.9M -189.69% | 17.8M +155.56% | -32.0M -41.23% | |
Net Income from Continuing Operations Applicable to Common | -71.2M +346.22% | -15.9M -189.69% | 17.8M +155.56% | -32.0M -48.80% | |
Basic EPS and Net Income | -2.06 -13.81% | -2.39 -189.51% | 2.67 +155.86% | -4.78 +986.36% | |
Diluted EPS and Net Income | -2.06 -13.81% | -2.39 -189.51% | 2.67 +155.86% | -4.78 +856.00% | |
Basic Weighted Average Shares | 34.6M +418.67% | 6.7M 0.00% | 6.7M 0.00% | 6.7M -94.65% | |
Diluted Weighted Average Shares | 34.6M +418.67% | 6.7M 0.00% | 6.7M 0.00% | 6.7M -94.68% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 5.7M -68.32% | 18.0M +386.13% | 3.7M -78.08% | 16.9M +7.41% | |
Short-Term Investments | N/A N/A | 0 -100.00% | 34.6M -58.66% | 83.8M -39.07% | |
Cash and Cash Equivalents and Short-Term Investments | 5.7M -68.32% | 18.0M -53.03% | 38.3M -61.92% | 100.7M -34.30% | |
Total Current Assets | 6.1M -66.42% | 18.3M -55.15% | 40.8M -62.09% | 107.5M -35.66% | |
Accumulated Depreciation | N/A N/A | 1.8M 0.00% | 1.8M +70.60% | 1.0M +59.57% | |
Property and Plant and Equipment and Net | N/A N/A | 0 -100.00% | 392,000 -70.05% | 1.3M -21.14% | |
Total Long-Term Assets | 652,000 N/A | 0 -100.00% | 392,000 -70.05% | 1.3M -21.14% | |
Total Assets | 42.7M +133.48% | 18.3M -55.81% | 41.4M -65.75% | 120.8M -32.07% | |
Income Taxes Payable | 40,000 N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 1.1M -21.05% | 1.4M -83.79% | 8.4M -58.92% | 20.3M -16.79% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 0 N/A | 0 N/A | 0 -100.00% | 75.8M -23.68% | |
Total Liabilities | 1.1M -21.05% | 1.4M -83.79% | 8.4M -91.31% | 96.2M -23.31% | |
Retained Earnings | -475.3M +17.60% | -404.2M +4.11% | -388.2M -4.38% | -406.0M +8.51% | |
Total Stockholders Equity | 41.6M +145.84% | 16.9M -48.73% | 33.0M +34.10% | 24.6M -53.02% | |
Total Shares Outstanding | 32.4M +386.37% | 6.7M 0.00% | 6.7M 0.00% | 6.7M -95.00% | |
Cash Flow | |||||
Cash from Operating Activities | -9.1M -56.24% | -20.8M -58.70% | -50.5M -3.83% | -52.5M +7.67% | |
Capital Expenditures | N/A N/A | 0 N/A | N/A N/A | 35,000 -92.69% | |
Cash from Investing Activities | -95.1M -370.57% | 35.1M -28.47% | 49.1M -8.47% | 53.7M +679.02% | |
Dividends Paid | N/A N/A | 0 -100.00% | 11.7M N/A | N/A N/A | |
Cash from Financing Activities | 91.9M N/A | 0 +100.00% | -11.9M +29,570.00% | -40,000 -100.08% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | N/A N/A | N/A N/A | 22.27% +133.97% | -65.55% -64.66% | |
Return on Assets | -233.37% +336.58% | -53.45% -343.82% | 21.92% +202.30% | -21.43% -30.75% | |
Return on Equity | -243.02% +280.66% | -63.84% -203.50% | 61.68% +174.25% | -83.08% -22.28% | |
Revenue Growth | N/A N/A | -100.00% -396.20% | 33.76% +69.23% | 19.95% +17.64% | |
Current Ratio | 5.74 -57.46% | 13.50 +176.75% | 4.88 -7.70% | 5.29 -22.68% | |
Cash Ratio | 5.34 -59.87% | 13.30 +2,900.02% | 0.44 -46.66% | 0.83 +29.09% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow